Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Small change in the NAMO. Look for a big move in the market in the next 2 days.
CDTI making that move.
CDTI flirting with the weekly ma 50. Might need to take a few runs at it.
GIG starting to roll now.
WGBS $1.05 close. $1.12 x 1.14 P.M.
SYN $2.42
Grant Awarded to Synthetic Biologics' Academic Collaborator to Fund Further Evaluation of Monoclonal Antibody for the Prevent...
Synthetic Biologics, Inc. (AMEX:SYN)
ROCKVILLE, Md. and AUSTIN, Texas, Oct. 21, 2015 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, and its Pertussis academic collaborator, The University of Texas at Austin (UT Austin), today announced a grant award of $400,000 to evaluate the potential of Synthetic Biologics' monoclonal antibody, hu1B7, to prevent Pertussis in non-human primates and provide support for its potential clinical application.
Synthetic Biologics, Inc. Logo.
Through its Exclusive Channel Collaboration with Intrexon Corporation (NYSE: XON) and academic researchers at UT Austin, Synthetic Biologics is currently developing SYN-005, a combination of two humanized antibodies that includes hu1B7, for the treatment of critically ill infants with Pertussis. The Gates Foundation has awarded a grant to UT Austin to generate preclinical proof-of-concept data to test the hypothesis that antibody administration at birth may also have a role in the prevention of Pertussis. Jennifer Maynard, Ph.D., the principal investigator of the grant, will test this hypothesis by using hu1B7 provided by Synthetic Biologics.
Developing a Pertussis prophylaxis is an urgent unmet medical need. According to the World Health Organization, Pertussis is responsible for up to 300,000 deaths each year, primarily among infants during the first four months of life. Administration of hu1B7 at birth has the potential to provide four months of prophylaxis and to save thousands of lives each year.
Dr. Jennifer Maynard, associate professor in the McKetta Department of Chemical Engineering at UT Austin, has conducted research to develop Pertussis therapies for more than a decade. Upon notification of the grant award, Dr. Maynard stated, "We are thrilled to be working with the Gates Foundation. This grant provides the opportunity to translate our academic efforts into a potential life-saving Pertussis prevention for infants throughout the world."
"It's a privilege to work with our collaborators to address the global re-emergence of Pertussis as a rising public health concern," noted Jeffrey Riley, CEO of Synthetic Biologics. "We believe Synthetic Biologics' novel prophylactic and therapeutic monoclonal antibody approaches have long-term potential to both protect newborns from Pertussis and treat newborns with Pertussis."
Hey kj. Good to know. Down day coming maybe.
Hi $H, doing fine, just stopped by to check the charts, I rarely look here anymore, due to the popups. I don't pay the fee anymore, so I don't use or need the private messages
HTM starting to look better!! im long
Holding tight to ROX my friend. There will be quite a bit to read in the upcoming quarterly report.
AKS nice break-out on heavy volume today.
I didn't hear the oil inventory report. UWTI up 6% on heavy volume. Ty.
Oil reports - inventories down and UWTI/USO are popping with volume
SYMX, $1.29 news.
Synthesis Energy Systems, Inc. Enters Definitive Agreements on $26M Package for Its Zao Zhuang New Gas Company Gasification Facility Expansion
8:32 am ET June 29, 2015 (Benzinga) Print
Synthesis Energy Systems, Inc. (SES) (NASDAQ: SYMX), a global energy and gasification technology company enabling clean, high-value energy and chemical products from multiple feedstocks announced that it has entered into a definitive Share Purchase and Investment Agreement (SPIA) with Rui Feng Enterprises Limited, a British Virgin Islands company and a separate Operation and Management (OM) Agreement with Shandong Saikong Automation Equipment Co. Ltd, an affiliate of Rui Feng registered in the People's Republic of China (together referred to as "the Transaction Partners") to achieve SES' strategic aim of repurposing and expanding its Zao Zhuang New Gas Company joint venture facility (ZZ) in Zao Zhuang City, Shandong Province, China. The agreements became effective on June 26, 2015, with the first installment payment of $1.6 million received by SES in its account outside China.
The transaction for selling SES' shares of the ZZ joint venture is to be completed offshore of the People's Republic of China. Under the terms of the SPIA agreement, the Transaction Partners will pay $10 million cash to SES in four installments over a period of 15 months for 59.81% of SES's shares in ZZ. The Transaction Partners will also invest a minimum additional equity of $6.6 million (40 million Yuan) to fund the estimated $16 million (100 million Yuan) expansion and increase its ownership to a capped limit of 73.53%. Additional debt financing will be raised by the Transaction Partners and the ZZ joint venture for completion of the expansion. SES is not required to invest additional equity or provide debt to the expanded ZZ facility and will retain a minimum 24.52% ownership in the new enterprise.
A separate Operation and Management Agreement between the Transaction Partners and the ZZ plant has also been signed which establishes a new General Manager of ZZ and a project team to carry forward on both day to day plant operations as well as oversee the construction of the expansion project. Under the terms of the OM agreement the Transaction Partners will finance all operating costs of the ZZ Plant and have preferential profit distribution right for the first 36 months of operations from the expanded facility.
The two existing SES gasification systems will be refurbished and prepared for full capacity operation and the syngas will be used for the production of 100,000 tons per year of acetic acid, as well as a secondary product of propionic acid (~10,000tpa). The agreed goal is to complete the expansion within 24 months. The parties will now work closely together to immediately amend the ZZ plant's existing facility's local government approvals to allow for production of the new products and begin equipment financing and engineering for the expansion. In addition, the ZZ plant will continue to generate methanol from Xuecheng Energy's coke oven gas (COG) under the terms of the existing Methanol Cooperation Agreement between ZZ and Shandong Weijiao Group Xuecheng EnergyCo., Ltd.
"I am proud of our team to have found such an enthusiastic partner with a solid commitment to expand the ZZ plant. This expansion is expected to allow our two SES gasification systems to operate at 100% design capacity which will drive lower unit costs for the new enterprise plus the production of acetic acid and the related products is expected to provide higher profitability through improved operating margins which we believe will produce long-term financial results from the ZZ joint venture," said Robert W. Rigdon, President and CEO of SES. "This move accomplishes our strategic aim to both monetize a portion of the ZZ asset and repurpose the facility for growth and future earnings without additional equity or debt required from SES. A lot of hard work still remains to secure the additional financing and complete the expansion project and we will be working closely with our new partners to get it done successfully."
"Through friendly cooperation of all parties we will undertake a great project expansion effort to create value for our shareholders. Zao Zhuang is a preferable location to place this important acetic acid production facility and improve the overall conditions for the area," said Madame Li Bing, General Manager of Rui Feng. "We are utilizing an advanced downstream technology that has been commercially proven to generate acetic acid at favorable economics and we will now put all efforts to move quickly toward our goal of a big project success."
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
HELI, in today at .62. Ambulance chasers are running out of time.
CDTI, going a/hs...
CDTI, trying to lift-off... needs to break $2.21
OCLS heavy, heavy volume.
OCLR volume already over twice it's avg 10 day.
OCLS watching the dip, popped on this article with great volume: http://finance.yahoo.com/news/panning-golden-stocks-outside-gold-132000598.html
OCLR, still going.
OCLR, thx. I'll get it up.
OCLR is worth watching, weekly is a must see chart, insiders have been buying and short interest ratio is pretty high at 18.26
My good friend, Command Sergeant Major Eric Cooke.
Eric and I served together as young platoon sergeants in Germany and then in Iraq on the Ready First Combat team. We were very competitive in everything we did but we always had each others back. I never had the pleasure of serving with him again.
Eric died as a result of an IED on Christmas Eve, 2003. Rest in Peace my friend.
http://www.arlingtoncemetery.net/efcooke.htm
LSG $1.03, golden cross. Needs to break $1.04. Link back for chart.
MNGA, close $1.32.
$35 Billion Energy Company Requests MagneGas® Demo
Today : Tuesday 19 May 2015
Click Here for more Magnegas Corp. - Common Stcok (MM) Charts.
TAMPA, Fla., May 19, 2015 /PRNewswire/ -- MagneGas Corporation ("MagneGas" or the "Company") (NASDAQ: MNGA), a leading technology company that counts among its inventions a patented process that converts liquid waste into MagneGas® fuel, announced today that it successfully completed a MagneGas2® presentation to a second top ten utility company in the United States. Formal demonstration and testing has been scheduled for June. In February, MagneGas2® was accepted by one of the nation's top 5 utilities as a replacement for acetylene because of its improved productivity and safety features.
Officials for the company viewed a MagneGas presentation and indicated an interest in MagneGas® productivity and safety features. A formal demonstration and testing is scheduled for June, during which time the utility company indicated they would invite other local utility companies in the area to attend. They specified that they were interested in using MagneGas® for repairs and demolition projects.
"We continue to have major industry leaders contact us to learn about MagneGas. The industrial gas market is clearly open to innovative, disruptive products that can positively impact our environment and the workplace. MagneGas2 is one of those new products that is expanding our market share with the growing demand and recognition for our products. We are excited at the enormity of these opportunities presented to us in just the last 30 days. Our commitment for our shareholders is to continue to establish MagneGas as the standard for safety and usability," stated Ermanno Santilli, CEO Magnegas Corporation.
LSG, golden cross maybe 2 days away if trend continues. Link back for chart.
FSI, $1.38.
VICTORIA, BC / ACCESSWIRE / May 15, 2015 / FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE Amex: FSI, FRANKFURT: FXT), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry. Flexible Solutions also manufactures biodegradable and environmentally safe water and energy conservation technologies. Today the Company announces financial results for the first quarter (Q1) ended March 31, 2015.
Mr. Daniel B. O'Brien, CEO, states, "Q1, 2015 shows significant growth in revenue, income and cash flow compared to the year earlier period. This follows the same pattern as the last half of 2014 and is very satisfying. We anticipate that the hard work of our skilled team will allow this pattern to continue."
- Sales in the first quarter (Q1) were $4,963,887, up approximately 30% when compared to sales of $3,812,981 in the corresponding period a year ago. The financials show a Q1, 2015 net income of $504,265, or $0.04 per share, compared to a net loss of $155,578, or $0.01 per share, in Q1, 2014.
-Basic weighted average shares used in computing per share amounts in Q1 were 13,169,991 for both 2015 and 2014.
- Non-GAAP operating cash flow: For the 3 months ending March 31, 2015, net income reflects $221,292 of non-cash charges (depreciation and stock option expenses), income tax, as well as gain or loss on sale of equipment and interest income which are items not related to operating or current operating activities. When these items are removed, the Company shows operating cash flow of $1,107,305, or $0.8 per share. This compares with operating cash flow of $65,714, or $0.00 per share, in the corresponding 3 months of 2014 (see the table that follows for details of these calculations).
The NanoChem division continues to produce most of FSI's revenue and cash flow. New opportunities continue to arise that may further increase sales in this division.
* a conference call has been scheduled for 11:00 am Eastern Time, 8:00 am Pacific Time, on Monday May 18, 2015. CEO, Dan O'Brien will be presenting and answering questions on the conference call. To participate in this call please dial 1-888-427-9376 (or 1-719-325-2393) just prior to the scheduled call time. The conference call title, "First Quarter 2015 Financials," may be requested.
EGAN, heavy volume too. Just woke up. I'll get it up.
EGAN is popping, short squeeze potential
Small change in the NAMO. Look for a big move in the market in the next 2 trading days.
GIGA I scalped it, can't stick around today
GIGA, heavy volume for a 3.4 mil float.
GIGA News out $3 million order
GEVO, I missed it and looks like good volume today and A/Hs as well and up an additional 16% too.
I'll watch for it tomorrow.
GEVO up A/H on earnings, Conference call is happening now
CDTI, nice news. Up 24%.
TBRA, watching for a little pullback to add.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |